ATYR
aTyr Pharma
ATYR
ATYR
56 hedge funds and large institutions have $84.3M invested in aTyr Pharma in 2024 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
12% more capital invested
Capital invested by funds: $75.1M → $84.3M (+$9.18M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6.58% less ownership
Funds ownership: 69.73% → 63.15% (-6.6%)
Holders
56
Holding in Top 10
1
Calls
$53K
Puts
$5K
Top Buyers
| 1 | +$1.79M | |
| 2 | +$612K | |
| 3 | +$590K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$258K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$245K |
Top Sellers
| 1 | -$1.76M | |
| 2 | -$1.55M | |
| 3 | -$488K | |
| 4 |
CC
Checkpoint Capital
San Francisco,
California
|
-$370K |
| 5 |
Renaissance Technologies
New York
|
-$255K |